New guidance on how to taper and discontinue from psychiatric drugs from leading researchers Mark Horowitz and David Taylor.
“Patients expressed feeling unaccepted by society or uncomfortable in their own skin… A few indicated that they would rather be dead than have tardive dyskinesia.”
Long-term exposure to prolactin-increasing antipsychotics increases the odds of developing breast cancer.
Researchers developed a rating scale to better assess service users’ experiences tapering antidepressant and/or antipsychotic medication.
In JAMA psychiatry, researchers outline new theories connecting antipsychotic use in people with schizophrenia and increased dementia risk.
A new study finds that newborn babies experience antidepressant withdrawal after birth if their mothers take SSRIs when pregnant.
Research finds that social cognition and emotional processing abilities can be disrupted by psychiatric drugs.
Research suggests that slowly tapering off an antipsychotic reduces the risk of withdrawal psychosis compared to abrupt discontinuation.
A new study investigates how antidepressant withdrawal effects often get confounded with depression relapse in clinical trials.
A new article in Lancet Psychiatry debunks past studies claiming that those on low doses of antipsychotics are more likely to relapse.
A study of over 1.5 million people in Europe and the US links the development of less adaptive personalities with childhood lead exposure.
Researchers argue for a shift away from a focus on antipsychotic adherence toward understanding service users’ diverse patterns of use.
The CHR-P model focuses on “attenuated psychosis” to predict “transition” to schizophrenia and ignores other factors. But new research shows that the model is a poor predictor.
Evolutionary theorists suggest that antidepressants interfere with the adaptive function of depression and propose a test of this theory.
A new study explores effective forms of grief support, finding that animals are more effective than humans in providing support.
Researchers push for a renewed focus on true shared decision-making for patients diagnosed with psychosis.
Researchers again debunk the claim that the FDA black box warnings on antidepressants led to more suicides.
Researchers question the long-term use of antipsychotics and suggest increased research and investment in psychosocial interventions.
“Short and simple psychological programs can prevent people from relapsing when they stop their antidepressants.”
Hanna Pickard on the elusive middle ground between personal responsibility and systemic factors in our understandings of addiction.
The prominent psychiatrist explores why antidepressants remain highly overprescribed and offers solutions to the problem.
Researchers have found further evidence that the anticholinergic effect of psychiatric drugs can lead to cognitive impairments.
The FDA collaborated with Biogen to conduct repeated re-analyses of aducanumab for Alzheimer's and FDA committee members are raising concerns.
Medical researchers present evidence that ADHD is overdiagnosed in children and teens, which can lead to significant harm.
While professional guidelines recommend antidepressants for back pain, researchers point out the lack of evidence for their usefulness.